Daniel Neureiter

8.5k total citations
241 papers, 5.9k citations indexed

About

Daniel Neureiter is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Daniel Neureiter has authored 241 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 78 papers in Oncology and 70 papers in Surgery. Recurrent topics in Daniel Neureiter's work include Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers), Histone Deacetylase Inhibitors Research (22 papers) and Epigenetics and DNA Methylation (21 papers). Daniel Neureiter is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers), Histone Deacetylase Inhibitors Research (22 papers) and Epigenetics and DNA Methylation (21 papers). Daniel Neureiter collaborates with scholars based in Austria, Germany and United States. Daniel Neureiter's co-authors include Tobias Kiesslich, Thomas Aigner, Matthias Ocker, E. Klieser, Pietro Di Fazio, Martin Pichler, Christian Mayr, Eckhart G. Hahn, Beate Alinger and Thomas Kirchner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel Neureiter

232 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Neureiter Austria 42 2.1k 1.5k 1.2k 906 863 241 5.9k
Adrian C Bateman United Kingdom 40 1.2k 0.6× 2.0k 1.3× 1.6k 1.3× 623 0.7× 853 1.0× 154 5.4k
Keith R. McCrae United States 56 2.6k 1.2× 1.1k 0.7× 1.2k 1.0× 1.1k 1.2× 966 1.1× 252 10.8k
Corrado Rubini Italy 40 2.4k 1.1× 1.7k 1.1× 1.0k 0.9× 997 1.1× 660 0.8× 261 6.2k
Franco Silvestris Italy 41 2.6k 1.2× 2.5k 1.7× 640 0.5× 1.1k 1.2× 630 0.7× 216 7.5k
Leonidas G. Koniaris United States 40 1.7k 0.8× 2.6k 1.7× 2.0k 1.7× 624 0.7× 1.3k 1.5× 127 7.0k
Shosaku� Nomura Japan 46 2.0k 0.9× 1.1k 0.8× 744 0.6× 503 0.6× 941 1.1× 310 6.5k
Tomayoshi Hayashi Japan 43 1.9k 0.9× 1.5k 1.0× 1.9k 1.6× 959 1.1× 3.1k 3.6× 336 7.5k
Masanori Nojima Japan 37 2.3k 1.1× 1.2k 0.8× 1.1k 1.0× 781 0.9× 1.0k 1.2× 322 5.4k
Asta Försti Germany 40 2.8k 1.3× 1.8k 1.2× 560 0.5× 1.6k 1.8× 661 0.8× 312 6.3k
Mark W. Lingen United States 51 2.8k 1.3× 2.0k 1.3× 1.6k 1.3× 1.2k 1.3× 1.3k 1.5× 175 7.6k

Countries citing papers authored by Daniel Neureiter

Since Specialization
Citations

This map shows the geographic impact of Daniel Neureiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Neureiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Neureiter more than expected).

Fields of papers citing papers by Daniel Neureiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Neureiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Neureiter. The network helps show where Daniel Neureiter may publish in the future.

Co-authorship network of co-authors of Daniel Neureiter

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Neureiter. A scholar is included among the top collaborators of Daniel Neureiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Neureiter. Daniel Neureiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rendl, Gundula, Jan Marco Kern, Lenka Bašková, et al.. (2025). Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei. Haematologica. 111(3). 1120–1124.
3.
Oberhuber, Rupert, et al.. (2025). The importance of preclinical models for cholangiocarcinoma drug discovery. Expert Opinion on Drug Discovery. 20(2). 205–216. 2 indexed citations
4.
Kiesslich, Tobias, Matthias Ocker, Martina Winklmayr, et al.. (2024). The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells. PLoS ONE. 19(4). e0302050–e0302050. 4 indexed citations
5.
Lafarge, Maxime W., Enric Domingo, Korsuk Sirinukunwattana, et al.. (2024). Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology. 8(1). 89–89. 9 indexed citations
6.
Neureiter, Daniel, Marlena Beyreis, Markus Ritter, et al.. (2023). Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. Cancers. 15(5). 1569–1569. 13 indexed citations
7.
Weghuber, Daniel, René G. Feichtinger, Sara Huber, et al.. (2022). Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease. Antioxidants. 11(11). 2235–2235. 13 indexed citations
8.
Ocker, Matthias, Christian Mayr, Sebastian Stintzing, et al.. (2022). Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers. 14(7). 1826–1826. 45 indexed citations
9.
Schneider, Anna-Maria, Franz Zimmermann, Susanne M. Brunner, et al.. (2022). Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 9151169–9151169. 9 indexed citations
10.
Steiner, M., Franz Josef Gassner, Daniel Neureiter, et al.. (2021). A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report. International Journal of Molecular Sciences. 22(17). 9410–9410. 2 indexed citations
11.
Mayr, Christian, Tobias Kiesslich, Marlena Beyreis, et al.. (2021). HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer. Cancers. 13(15). 3862–3862. 22 indexed citations
12.
Neureiter, Daniel, Markus Ritter, Martin Jakab, et al.. (2020). Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review. Journal of Clinical Medicine. 9(4). 1200–1200. 10 indexed citations
13.
14.
Laurent‐Puig, Pierre, Volker Heinemann, Daniel Neureiter, et al.. (2018). Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research. 25(1). 134–141. 31 indexed citations
15.
Tanwar, Sudeep, Paul Trembling, Brian Hogan, et al.. (2016). Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C. Journal of Clinical Gastroenterology. 51(3). 268–277. 9 indexed citations
16.
Krenn, Peter W., Sebastian W. Hofbauer, Ursula Denk, et al.. (2016). ILK Induction in Lymphoid Organs by a TNFα–NF-κB–Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia. Cancer Research. 76(8). 2186–2196. 12 indexed citations
17.
Stintzing, Sebastian, Wu Zhang, Volker Heinemann, et al.. (2015). Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. Molecular Cancer Therapeutics. 14(10). 2374–2381. 5 indexed citations
18.
Quint, Karl, Daniel Neureiter, Christopher Nimsky, et al.. (2014). The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas. Tumor Biology. 35(9). 8979–8989. 41 indexed citations
19.
Girbl, Tamara, Eva Melanie Grössinger, Daniela Asslaber, et al.. (2012). CD40-Mediated Activation of Chronic Lymphocytic Leukemia Cells Promotes Their CD44-Dependent Adhesion to Hyaluronan and Restricts CCL21-Induced Motility. Cancer Research. 73(2). 561–570. 32 indexed citations
20.
Fazio, Pietro Di, Regine Schneider‐Stock, Daniel Neureiter, et al.. (2010). The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis. SHILAP Revista de lepidopterología. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrian C Bateman Breakdown of academic impact, for papers by Keith R. McCrae Breakdown of academic impact, for papers by Corrado Rubini Breakdown of academic impact, for papers by Franco Silvestris Breakdown of academic impact, for papers by Leonidas G. Koniaris Breakdown of academic impact, for papers by Shosaku� Nomura Breakdown of academic impact, for papers by Tomayoshi Hayashi Breakdown of academic impact, for papers by Masanori Nojima Breakdown of academic impact, for papers by Asta Försti Breakdown of academic impact, for papers by Mark W. Lingen
Rankless by CCL
2026